These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10999926)

  • 1. Screening for Down's syndrome. Statistical modelling is best tool for formulating screening policy.
    Cuckle H
    BMJ; 2000 Sep; 321(7263):763; author reply 764-5. PubMed ID: 10999926
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for Down's syndrome. Serum screening shows a clear benefit across age groups.
    McCune GS; Stock AS; Foakes A
    BMJ; 2000 Sep; 321(7263):762-3; author reply 764-5. PubMed ID: 10999924
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for Down's syndrome. Serum screening programmes are effective and safe.
    Wald NJ; Hackshaw AK; Huttly W
    BMJ; 2000 Sep; 321(7263):763-4; author reply 764-5. PubMed ID: 10999927
    [No Abstract]   [Full Text] [Related]  

  • 4. Antenatal screening policies for Down's syndrome. Serum screening for Down's syndrome is better than age screening.
    Christiansen M; Larsen SO; Nørgaard-Pedersen B
    BMJ; 2002 Nov; 325(7371):1034; author reply 1034. PubMed ID: 12420332
    [No Abstract]   [Full Text] [Related]  

  • 5. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies.
    Morris JK; Wald NJ
    J Med Screen; 2007; 14(1):5-7. PubMed ID: 17362564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
    Reynolds T; Ellis A; Jones R
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):464-8. PubMed ID: 15588435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Down's syndrome. Data do not support study's claim.
    Norgaard-Pedersen B
    BMJ; 2000 Sep; 321(7263):763; author reply 764-5. PubMed ID: 10999925
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for Down's syndrome. Biochemical screening offers advantages.
    Boyd PA; Jefferies M; Chamberlain PF; Crocker AJ
    BMJ; 2000 Sep; 321(7263):762; author reply 764-5. PubMed ID: 10999923
    [No Abstract]   [Full Text] [Related]  

  • 9. Antenatal screening policies for Down's syndrome. Audit of Down's syndrome screening is not valid.
    Wald NJ; Huttly W; Hackshaw AK
    BMJ; 2002 Nov; 325(7371):1034; author reply 1034. PubMed ID: 12411371
    [No Abstract]   [Full Text] [Related]  

  • 10. Down's syndrome: screening and antenatal diagnosis regionally in England and Wales 1989-2008.
    De Souza E; Alberman E; Morris JK
    J Med Screen; 2010; 17(4):170-5. PubMed ID: 21258126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prenatal genetic diagnosis and Down's syndrome].
    Srsen S; Srsnová K
    Cesk Gynekol; 1986 May; 51(4):271-4. PubMed ID: 2941168
    [No Abstract]   [Full Text] [Related]  

  • 12. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Down's syndrome. Modelling does not predict reality accurately.
    Howe D
    BMJ; 2002 Jan; 324(7329):111-2. PubMed ID: 11808523
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary prevention of Down's syndrome in Czechoslovakia 1975-1980].
    Kucera J
    Cesk Pediatr; 1982 Jul; 37(7):404-8. PubMed ID: 6215132
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What you need to know about... Down's syndrome.
    Nurs Times; 2003 Jun 3-9; 99(22):28. PubMed ID: 12808746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.